Genetic-based model for predicting outcomes in primary myelofibrosis
A group of investigators from Mayo Clinic and multiple academic research centres in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease. “Myelofibrosis is a rare type of chronic leukemia that disrupts the body’s […]
